NASDAQ : KRRO
Korro Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 14.315 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 210.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Korro Bio, Inc. (KRRO) reported revenue of 2.38M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.38M | 6.39M | 2.27M | |||
| Cost of Revenue | 43.41M | 55.13M | 52.31M | 48.00M | ||
| Gross Profit | -41.02M | -48.74M | -50.04M | -48.00M | ||
| Selling, General & Admin | 35.88M | 38.60M | 41.87M | 36.54M | 21.39M | 14.06M |
| Research & Development | 37.61M | 21.43M | ||||
| Operating Expenses | 35.88M | 38.60M | 41.87M | 36.54M | 59.00M | 35.49M |
| Operating Income | -76.90M | -87.34M | -91.91M | -84.53M | -59.00M | -35.49M |
| Other Non Operating Income (Expenses) | 5.23M | 5.23M | 8.47M | 3.39M | 976.00K | 13.54M |
| EBT Excluding Unusual Items | -72.53M | -82.11M | -83.44M | -81.14M | -58.02M | -21.96M |
| Merger & Restructuring Charges | -2.39M | -3.63M | ||||
| Asset Writedown | -30.89M | -30.89M | ||||
| Pretax Income | -105.81M | -116.62M | -83.44M | -81.14M | -58.02M | -21.96M |
| Income Tax Expense | 839.00K | 637.00K | 141.00K | 27.00K | 10.00K | 2.00K |
| Net Income | -106.64M | -117.26M | -83.58M | -81.17M | -58.03M | -21.96M |
| Net Income to Common | -106.64M | -117.26M | -83.58M | -81.17M | -58.03M | -21.96M |
| Shares Outstanding (Basic) | 12.01M | 9.40M | 8.92M | 1.53M | 255.18K | 4.45M |
| Shares Outstanding (Diluted) | 12.01M | 9.40M | 8.92M | 1.53M | 255.18K | 4.45M |
| EPS (Basic) | -8.88 | -12.48 | -9.37 | -53.08 | -227.42 | -4.94 |
| EPS (Diluted) | -8.88 | -12.48 | -9.37 | -53.08 | -227.42 | -4.94 |
| Free Cash Flow | -68.27M | -79.08M | -77.98M | -75.12M | -58.86M | -36.54M |
| Free Cash Flow Per Share | -5.68 | -8.42 | -8.74 | -49.12 | -230.65 | -8.22 |
| Operating Margin | -3,228.34% | -1,366.43% | -4,047.12% | |||
| Profit Margin | -4,477.08% | -1,834.48% | -3,680.36% | |||
| Free Cash Flow Margin | -2,865.87% | -1,237.16% | -3,433.55% | |||
| EBITDA | -74.33M | -83.06M | -88.34M | -80.90M | -56.49M | -33.90M |
| D&A For EBITDA | 2.57M | 4.28M | 3.56M | 3.63M | 2.51M | 1.59M |
| EBIT | -76.90M | -87.34M | -91.91M | -84.53M | -59.00M | -35.49M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.91M | 21.82M | 55.64M | 166.15M | 36.33M | 83.49M |
| Short-Term Investments | 90.13M | 53.33M | 70.45M | 18.91M | 35.04M | |
| Cash & Short-Term Investments | 115.04M | 75.16M | 126.09M | 166.15M | 55.25M | 118.53M |
| Receivables | 969.00K | 1.70M | ||||
| Prepaid Expenses | 5.59M | 5.25M | 3.74M | 3.02M | 1.23M | 643.00K |
| Restricted Cash | 997.00K | 3.56M | 603.00K | 600.00K | ||
| Total Current Assets | 120.63M | 82.37M | 131.53M | 172.73M | 57.08M | 119.78M |
| Property, Plant & Equipment | 15.05M | 16.22M | 51.55M | 42.81M | 11.89M | 6.45M |
| Long-Term Investments | 22.89M | 10.03M | 36.96M | |||
| Other Long-Term Assets | 4.88M | 4.88M | 6.20M | 6.12M | 4.77M | 1.35M |
| Total Assets | 163.45M | 113.51M | 226.24M | 221.66M | 73.74M | 127.58M |
| Accounts Payable | 3.60M | 1.65M | 3.99M | 7.28M | 2.60M | 789.00K |
| Accrued Expenses | 5.07M | 7.61M | 6.17M | 9.82M | 3.17M | 3.22M |
| Current Portion of Leases | 2.94M | 2.67M | 1.28M | 1.99M | 2.92M | |
| Current Unearned Revenue | 1.02M | 3.51M | ||||
| Other Current Liabilities | 395.00K | 939.00K | ||||
| Total Current Liabilities | 12.63M | 11.94M | 14.96M | 19.48M | 8.70M | 4.95M |
| Long-Term Leases | 39.28M | 40.81M | 43.48M | 31.22M | 209.00K | |
| Long-Term Unearned Revenue | 6.81M | 7.83M | 5.91M | |||
| Other Long-Term Liabilities | 1.50M | 1.48M | 1.47M | 1.05M | 971.00K | |
| Total Liabilities | 60.22M | 62.07M | 65.83M | 51.75M | 8.91M | 5.92M |
| Common Stock | 14.00K | 9.00K | 9.00K | 8.00K | 5.00K | |
| Additional Paid-In Capital | 525.79M | 435.06M | 426.72M | 352.91M | 2.81M | 1.59M |
| Retained Earnings | -422.39M | -383.85M | -266.59M | -183.00M | -101.83M | -43.80M |
| Comprehensive Income & Other | -189.00K | 212.00K | 268.00K | -5.00K | -7.00K | |
| Total Common Equity | 103.23M | 51.44M | 160.41M | 169.91M | -99.03M | -42.21M |
| Shareholders' Equity | 103.23M | 51.44M | 160.41M | 169.91M | 64.83M | 121.66M |
| Total Liabilities & Equity | 163.45M | 113.51M | 226.24M | 221.66M | 73.74M | 127.58M |
| Total Debt | 42.21M | 43.49M | 44.77M | 33.21M | 3.13M | |
| Net Cash (Debt) | 95.71M | 41.70M | 118.29M | 132.94M | 52.12M | 118.53M |
| Net Cash Per Share | 7.97 | 4.44 | 13.26 | 86.93 | 204.24 | 26.65 |
| Filing Date Shares Outstanding | 14.73M | 14.42M | 9.39M | 8.02M | 5.64M | 4.45M |
| Total Common Shares Outstanding | 14.71M | 9.42M | 9.38M | 8.02M | 5.40M | 4.45M |
| Working Capital | 108.00M | 70.44M | 116.57M | 153.25M | 48.38M | 114.83M |
| Book Value Per Share | 7.02 | 5.46 | 17.11 | 21.20 | -18.33 | -9.49 |
| Tangible Book Value | 103.23M | 51.44M | 160.41M | 169.91M | -99.03M | -42.21M |
| Tangible Book Value Per Share | 7.02 | 5.46 | 17.11 | 21.20 | -18.33 | -9.49 |
| Machinery | 9.10M | 9.05M | 12.49M | 11.91M | 9.13M | 4.68M |
| Construction In Progress | 107.00K | 8.24M | 2.05M | 631.00K | ||
| Leasehold Improvements | 9.68M | 9.68M | 22.44M | 3.36M | 2.94M | 2.88M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -106.64M | -117.26M | -83.58M | -81.17M | -58.03M | -21.96M |
| Depreciation & Amortization | 2.57M | 4.28M | 3.56M | 3.63M | 2.51M | 1.59M |
| Loss (Gain) From Sale of Assets | -18.00K | 63.00K | 357.00K | 65.00K | 8.00K | |
| Asset Writedown & Restructuring Costs | 30.89M | 30.89M | ||||
| Loss (Gain) From Sale of Investments | -66.00K | -489.00K | -1.78M | -80.00K | -145.00K | 20.00K |
| Stock-Based Compensation | 9.33M | 7.66M | 4.46M | 2.38M | 1.14M | 807.00K |
| Other Operating Activities | 888.00K | 730.00K | 3.31M | 3.61M | 1.51M | -13.47M |
| Change in Accounts Receivable | 1.09M | 727.00K | -1.70M | |||
| Change in Accounts Payable | -1.55M | -2.31M | -1.34M | 3.10M | 1.75M | 56.00K |
| Change in Unearned Revenue | -593.00K | -1.59M | 9.43M | -686.00K | ||
| Change in Other Net Operating Assets | -3.84M | -1.25M | 7.20M | 1.18M | -2.39M | 1.53M |
| Operating Cash Flow | -67.95M | -78.56M | -60.07M | -67.28M | -53.65M | -32.09M |
| Capital Expenditures | -317.00K | -518.00K | -17.90M | -7.84M | -5.21M | -4.45M |
| Sale of Property, Plant & Equipment | 13.00K | |||||
| Investment in Securities | -27.31M | 44.51M | -105.44M | 19.00M | 16.27M | -35.07M |
| Investing Cash Flow | -27.63M | 43.99M | -123.35M | 11.16M | 11.06M | -39.50M |
| Issuance of Common Stock | 85.80M | 685.00K | 69.36M | 154.55M | 62.00K | 28.00K |
| Other Financing Activities | -12.25M | -44.00K | -30.00K | |||
| Financing Cash Flow | 85.80M | 685.00K | 69.36M | 187.76M | 18.00K | 115.94M |
| Foreign Exchange Rate Adjustments | 70.00K | 64.00K | -4.00K | |||
| Net Cash Flow | -9.70M | -33.82M | -114.07M | 131.64M | -42.57M | 44.35M |
| Free Cash Flow | -68.27M | -79.08M | -77.98M | -75.12M | -58.86M | -36.54M |
| Free Cash Flow Margin | -2,865.87% | -1,237.16% | -3,433.55% | |||
| Free Cash Flow Per Share | -5.68 | -8.42 | -8.74 | -49.12 | -230.65 | -8.22 |
| Levered Free Cash Flow | -41.39M | -49.36M | -69.99M | -47.69M | -38.20M | |
| Unlevered Free Cash Flow | -40.85M | -49.36M | -69.99M | -47.69M | -38.20M | |
| Cash Income Tax Paid | 108.00K | 1.00K | 141.00K | 27.00K | 11.00K | |
| Change in Working Capital | -4.90M | -4.43M | 13.59M | 4.28M | -633.00K | 904.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 210.80M | 75.43M | 356.65M | 383.31M | ||
| Enterprise Value | 115.09M | 17.61M | 229.32M | 577.73M | ||
| Last Close Price | 14.31 | 8.01 | 38.07 | 47.93 | ||
| PS Ratio | 88.50 | 11.80 | 157.04 | |||
| PB Ratio | 2.04 | 1.47 | 2.22 | 2.26 | ||
| P/TBV Ratio | 2.04 | 1.47 | 2.22 | 2.26 | ||
| EV/Sales Ratio | 48.32 | 2.75 | 100.98 | |||
| Debt / Equity Ratio | 0.41 | 0.84 | 0.28 | 0.20 | 0.05 | |
| Net Debt / Equity Ratio | -0.93 | -0.81 | -0.74 | -0.78 | -0.80 | -0.97 |
| Net Debt / EBITDA Ratio | 1.29 | 0.50 | 1.34 | 1.64 | 0.92 | 3.50 |
| Net Debt / FCF Ratio | 1.40 | 0.53 | 1.52 | 1.77 | 0.89 | 3.24 |
| Asset Turnover | 0.01 | 0.04 | 0.01 | |||
| Quick Ratio | 9.11 | 6.38 | 8.54 | 8.53 | 6.35 | 23.95 |
| Current Ratio | 9.55 | 6.90 | 8.79 | 8.87 | 6.56 | 24.20 |
| Return on Equity (ROE) | -97.69% | -110.70% | -50.60% | -69.16% | -62.24% | |
| Return on Assets (ROA) | -27.95% | -32.14% | -25.65% | -35.77% | -36.63% | |
| Return on Capital Employed (ROCE) | -51.00% | -86.00% | -43.50% | -41.80% | -90.70% | -28.90% |
| Earnings Yield | -62.01% | -155.45% | -23.43% | -21.18% | ||
| FCF Yield | -32.38% | -104.83% | -21.86% | -19.60% | ||
| Buyback Yield / Dilution | -28.33% | -5.32% | -483.30% | -499.32% | 94.26% |